Thu, January 22, 2009
Wed, January 21, 2009
Tue, January 20, 2009
Mon, January 19, 2009
Fri, January 16, 2009
Thu, January 15, 2009
Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009

Adolor Corporation to Present at 27th Annual J. P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. 7th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Monday, January 12th 2009 at 13:24 GMT, Last Modified on 2009-01-12 13:25:14 by Market Wire   Print publication without navigation


EXTON, Pa.--([ BUSINESS WIRE ])--Adolor Corporation (Nasdaq:ADLR) today announced that Michael R. Dougherty, President and Chief Executive Officer, will present at the 27th Annual J. P. Morgan Healthcare Conference on Thursday, January 15, 2009 at Noon Pacific Time (3:00 P.M. Eastern Time). The conference is being held at the Westin St. Francis Hotel in San Francisco, California.

Adolor's presentation will be webcast live for investors through [ www.adolor.com ] and available for a period of 14 days following the conference.

About Adolor Corporation

Adolor Corporation is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products.

Adolor's first approved product in the United States is ENTEREG®, which is indicated to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. ENTEREG is available for short-term use in hospitals registered under the ENTEREG Access Support and Education (E.A.S.E.TM) Program. In collaboration with GlaxoSmithKline, the company launched ENTEREG in mid-2008.

For more information, visit [ www.adolor.com ].

This press release is available on the website [ http://www.adolor.com ].


Publication Contributing Sources